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myocardial bridging may be highly overlooked in classical coronary angiography.
Additionally myocardial bridging on coronary arteries detected on MSCT Angiog-
raphy should strictly be sought, reported and also identiﬁed with its length,
compression and luminal narrowing. Those subjects should be followed with the
restriction from extremely strenuous exercise rather than mildly regular exercise. Beta
blocking drugs may be the best options of therapy in order to reduce the myocardial
oxygen demand and work load. Myocardial bridging may not be innocent due to its
potential to induce ischemia and LV dysfunction especially in young subjects.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POST
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Purpose: To assess whether single dose oral ivabradine referred for CCTA is safe and
can signiﬁcantly decrease the heart rate as compared to IV (intravenous) metoprolol in
patients who were receiving calcium channel blocker (CCB) therapy.
Methods: One-hundred-twenty patients who were under CCB therapy referred for
CCTA were randomized to premedication with single dose ivabradine 15 mg or IV
metoprolol 5-10 mg. Hearth rate (HR) were assessed at admission (HR0) and during
CTCA scan (HR1) for all patients. Blood pressure (BP) were measured before the
medication (BP0) and immediately before CCTA scan (BP1).
Results: Although the HR of the groups were not signiﬁcantly different before the
medication (HRIv0¼80  7bpm vs. HRb0¼81  7bpm; p¼0,42), Ivabradine
administration signiﬁcantly reduced HR during CCTA when compared to metoprolol
(HRIv1¼62  7 bpm vs. HRb1¼66  6 bpm; p¼0,001). Decreases in HR were for
Ivabradine (186 bpm) is signiﬁcantly higher than for metoprolol (15  4 bpm)
(p¼0,003) without relevant side effects. Ivabradine showed no signiﬁcant effect on
both systolic BP or the diastolic BP, (SiBPIv0: 13910, SiBPIv1: 13810, p¼0.260;
DiBPIv0: 81 7 DiBPIv1: 816 p¼0.59. Metoprolol group demonstrated statistically
signiﬁcant reduction in both SBP and DBP (SiBPb0:136 11, SiBPb1 13011,
p<0.001; DiBPb0: 816, DiBPb1: 78  6, p<0.001).
Conclusıon: Ivabradine is safe and signiﬁcantly effective in decreasing the HR when
compared to IV metoprolol in the patients who were under CCB therapy.
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Pulmonary hypertension is associated with different disease groups and has high
mortality risk. Eisenmenger syndrome, connective tissue disease and idiopathic form
cause pulmonary arterial hypertension (PAH). Rheumatismal mitral stenosis is the
leading cause of pulmonary venous hypertension (PVHT). Although it is very good
known that these disease cause right heart failure there are no study to compare the
degree of right ventricular alteration in these patient groups. We aimed to compare the
right ventricle functions between PAH and PVHT with echocardiography and to
compare ADMA levels which demonstrate endothelial dysfunction patients in group I
and group II had higher ADMA levels than control subjects. The levels of ADMA
were not different between patients with PAH and patients with PVHT.
RA area, RA major and minor dimensions, RVEDV, RVESV, systolic PAB, TV
systolic tissue Doppler velocity, RV wall thickness, RVOT proximal and distal
diameters were signiﬁcantly higher in group I patients with PAH than in group II
patients with PVHT. TV systol time, TV ejection time were similar between groups.
RVMPI and RVAC were higher in group II patients than in group I.
Group II patients divided to subgroups a; higher PVR and b; lower PVR in patients
with mitral stenosis according to Abbas Formula. RVMPI, RVFAC, TV systolic tissue
doppler velocity, ADMA levels were different between groups. Group IIa patients had
higher ADMA levels, MPI, TV systolic tissue doppler velocity and lower RVAFC
than group IIb patients.
Dıscussıon: PAH causes increased risk of mortality due to right heart failure. Right
heart failure may occur in patients with mitral stenosis in long term. Our study
demonstrated that PAH patients had worse right heart functions than PVHT patients as
expected. In patients with high PVR due to mitral stenosis if the operation is delayed
the prognosis will be the worse as shown in our study that group II patients with high
PVR has worse right heart functions than others. The other internetini ﬁnding of our
study is the similar ADMA levels between PAH and PVHT patients. In literatüre there
is no similar study. We can assume that ADMA level in pulmonary HT may
demonstrate the presence of pulmonary HT not the magnitude.ERS C85
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